TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:58
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) https://www.creativemedicaltechnology.com
2.32USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-50.11%
CELZ
SPY
32.66%
-88.85%
CELZ
SPY
108.59%
-98.97%
CELZ
SPY
302.52%
CELZ
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
3.23
-3.03
0.06
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.61
161.50
0.49
-128.35
0.00
0.63
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-13870.92
60.00
-17903.66
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
16.8688
-58.11
-37.91
3.41
Other Earnings and Cash Flow Stats:
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Net Income TTM ($MM) is -5.32
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Operating Income TTM ($MM) is -5.63
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Owners' Earnings Annual ($MM) is 0.00
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Current Price to Owners' Earnings ratio is 0.00
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) EBITDA TTM ($MM) is -5.50
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) EBITDA Margin is -17903.66%
Capital Allocation:
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) has paid 0.00 dividends per share and bought back 0.039142 million shares in the past 12 months
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Interest-bearing Debt ($MM) as of last quarter is 0
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Annual Working Capital Investments ($MM) are 6
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Book Value ($MM) as of last quarter is 6
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) has 6 million in cash on hand as of last quarter
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) has 0 million of liabilities due within 12 months, and long term debt 0 as of last quarter
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) has 1 common shares outstanding as of last quarter
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) has 0 million USD of preferred stock value
Academic Scores:
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Altman Z-Score is -8.23 as of last quarter
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) largest shareholder is owning shares at 0.00 ($MM) value
Timothy Warbington(an insider) Bought 800 shares of CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) for the amount of $3552.00 on 2023-06-27
2.10% of CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) is held by insiders, and 3.96% is held by institutions
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) went public on 2015-11-06
Other CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) financial metrics:
FCF:-5.45
Unlevered Free Cash Flow:0.00
EPS:-2.99
Operating Margin:-13870.92
Gross Profit Margin:60.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-63.45
Beta:3.41
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC. ( CELZ ) :
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.